Timing of elective surgery and risk assessment after SARS-CoV-2 infection: 2023 update: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Federation of Surgical Specialty Associations, Royal College of Anaesthetists and Royal College of Surgeons of England.
COVID-19
SARS-CoV-2
complications
surgery
timing
Journal
Anaesthesia
ISSN: 1365-2044
Titre abrégé: Anaesthesia
Pays: England
ID NLM: 0370524
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
accepted:
31
05
2023
medline:
7
8
2023
pubmed:
20
6
2023
entrez:
20
6
2023
Statut:
ppublish
Résumé
Guidance for the timing of surgery following SARS-CoV-2 infection needed reassessment given widespread vaccination, less virulent variants, contemporary evidence and a need to increase access to safe surgery. We, therefore, updated previous recommendations to assist policymakers, administrative staff, clinicians and, most importantly, patients. Patients who develop symptoms of SARS-CoV-2 infection within 7 weeks of planned surgery, including on the day of surgery, should be screened for SARS-CoV-2. Elective surgery should not usually be undertaken within 2 weeks of diagnosis of SARS-CoV-2 infection. For patients who have recovered from SARS-CoV-2 infection and who are low risk or having low-risk surgery, most elective surgery can proceed 2 weeks following a SARS-CoV-2 positive test. For patients who are not low risk or having anything other than low-risk surgery between 2 and 7 weeks following infection, an individual risk assessment must be performed. This should consider: patient factors (age; comorbid and functional status); infection factors (severity; ongoing symptoms; vaccination); and surgical factors (clinical priority; risk of disease progression; grade of surgery). This assessment should include the use of an objective and validated risk prediction tool and shared decision-making, taking into account the patient's own attitude to risk. In most circumstances, surgery should proceed unless risk assessment indicates that the risk of proceeding exceeds the risk of delay. There is currently no evidence to support delaying surgery beyond 7 weeks for patients who have fully recovered from or have had mild SARS-CoV-2 infection.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1147-1152Informations de copyright
© 2023 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.
Références
Abbott TEF, Fowler AJ, Dobbs TD, et al. Mortality after surgery with SARS-CoV-2 infection in England: a population-wide epidemiological study. British Journal of Anaesthesia 2021; 127: 205-14.
Bhangu A, Nepogodiev D, Glasbey JC, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396: 27-38.
COVIDSurg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 2021; 76: 748-58.
El-Boghdadly K, Cook TM, Goodacre T, et al. SARS-CoV-2 infection, COVID-19 and timing of elective surgery: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College. Anaesthesia 2021; 76: 940-6.
Rohatgi N, Smilowitz NR, Reejhsinghani R. Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of COVID-19. Journal of the American Medical Association Surgery 2022; 157: 187.
Australian and New Zealand College of Anaesthetists. Guideline on Surgical Patient Safety for SARS-CoV-2 Infection and Vaccination. 2022.
UK Health Security Agency. SARS-CoV-2 Variants of Concern and Variants under Investigation in England. Technical Briefing 34. 2022.
Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant Covid-19 outbreak in a large hospital in Tshwane, South Africa. International Journal of Infectious Diseases 2022; 116: 38-42.
El-Boghdadly K, Cook TM, Goodacre T, et al. Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England. Anaesthesia 2022; 77: 580-7.
Iketani S, Liu L, Guo Y, et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 2022; 604: 553-6.
Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 Omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 2022; 399: 1303-12.
Sigal A, Milo R, Jassat W. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nature Reviews Immunology 2022; 22: 267-9.
Hansen CH, Friis NU, Bager P, et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 Omicron subvariant: a nation-wide population-based study in Denmark. Lancet Infectious Diseases 2023; 23: 167-76.
The Lancet Rheumatology. Too long to wait: the impact of COVID-19 on elective surgery. Lancet Rheumatology 2021; 3: e83.
NHS England. Consultant-led referral to treatment waiting times data 2022-23. 2023. https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/rtt-data-2022-23/ (accessed 06/04/2023).
Sauro KM, Smith C, Kersen J, et al. The impact of delaying surgery during the COVID-19 pandemic in Alberta: a qualitative study. Canadian Medical Association Journal Open 2023; 11: E90-100.
Cook TM, Lawton T. Surgery soon after COVID-19: transparent big data have value but careful interpretation is still required. Anaesthesia 2023; 78: 671-6.
Garnier M, Constantin J-M, Cinotti R, et al. Association of preoperative COVID-19 and postoperative respiratory morbidity during the Omicron epidemic wave: the DROMIS-22 multicentre prospective observational cohort study. eClinicalMedicine 2023; 58: 101881.
SenthilKumar G, Verhagen NB, Sheriff SA, et al. Preoperative SARS-CoV-2 infection increases risk of early postoperative cardiovascular complications following non-cardiac surgery. American Journal of Physiology-Heart and Circulatory Physiology 2023; 4: 88-100.
McInerney CD, Kotzé A, Bacon S, et al. Postoperative mortality and complications in patients with and without pre-operative SARS-CoV-2 infection: a service evaluation of 24 million linked records using OpenSAFELY. Anaesthesia 2023; 78: 692-700.
Office for National Statistics. Coronavirus (COVID-19) Infection Survey, UK: 24 March 2023. 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest (accessed 06/04/2023).
COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia 2022; 77: 28-39.
Kougias P, Sharath SE, Zamani N, Brunicardi FC, Berger DH, Wilson MA. Timing of a major operative intervention after a positive COVID-19 test affects postoperative mortality: results from a nationwide, procedure-matched analysis. Annals of Surgery 2022; 276: 554-61.
Tenforde MW, Weber ZA, Natarajan K, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19 - associated Emergency Department or urgent care encounters and hospitalizations among immunocompetent adults - VISION Network, Nine States, September-November 2022. Morbidity and Mortality Weekly Report 2023; 71: 1637-46.
Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al. Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection - increasing community access to testing program, United States, September-November 2022. Morbidity and Mortality Weekly Report 2022; 71: 1526-30.
Chalkias S, Harper C, Vrbicky K, et al. A bivalent omicron-containing booster vaccine against COVID-19. New England Journal of Medicine 2022; 387: 1279-91.
Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021; 397: 1819-29.
Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review. Anaesthesia 2020; 75: 920-7.
Bhangu A, Nepogodiev D. COVIDsurg 3 - Changing global practice. IRCAD France, 2022. https://www.youtube.com/live/UjILbjG6EIE?feature=share (accessed 18/05/2023).
NHS England. Delivery plan for tackling the COVID-19 backlog of elective care. 2022. https://www.england.nhs.uk/coronavirus/publication/delivery-plan-for-tackling-the-covid-19-backlog-of-elective-care/ (accessed 17/04/2023).
Wong DJN, Harris S, Sahni A, et al. Developing and validating subjective and objective risk-assessment measures for predicting mortality after major surgery: an international prospective cohort study. PLoS Medicine 2020; 17: e1003253.
Vernooij JEM, Koning NJ, Geurts JW, Holewijn S, Preckel B, Kalkman CJ, Vernooij LM. Performance and usability of pre-operative prediction models for 30-day peri-operative mortality risk: a systematic review. Anaesthesia 2023; 78: 607-19.